01 1LXO IRELAND
02 3OMNIVIUM PHARMS
01 410016407
01 4Blank
01 4Blank
01 42037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10016407
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2329
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10016407
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2226
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10016407
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2225
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10016407
Drug Substance Claim :
Drug Product Claim :
Application Number : 209963
Patent Use Code : U-2329
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
